Aurélie De Bruycker

PhD Thesis

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Aurélie De Bruycker (UGent)

(2022)

Journal Article
A1
open access

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

MP Deek, K Van der Eecken, P Sutera, RA Deek, Valerie Fonteyne (UGent) , AA Mendes, Karel Decaestecker (UGent) , AP Kiess, Nicolaas Lumen (UGent) , R Phillips, et al.

(2022) JOURNAL OF CLINICAL ONCOLOGY. 40(29). p.3377-3382

Add to list

Journal Article
A1
open access

PEACE V : salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM) : a study protocol for a randomized controlled phase II trial

Aurélie De Bruycker (UGent) , An Spiessens (UGent) , P. Dirix, N. Koutsouvelis, I. Semac, N. Liefhooghe, A. Gomez-Iturriaga, W. Everaerts, F. Otte, A. Papachristofilou, et al.

(2020) BMC CANCER. 20(1).

Add to list

Journal Article
A1
open access

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Elise De Bleser, Ruben Willems (UGent) , Karel Decaestecker (UGent) , Lieven Annemans (UGent) , Aurélie De Bruycker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Filip Ameye, Ignace Billiet, Steven Joniau, et al.

(2020) CANCERS. 12(1).

Add to list

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Aurélie De Bruycker (UGent) , Valerie Fonteyne (UGent) and Piet Ost (UGent)

(2019) EUROPEAN UROLOGY. 76(5). p.E146-E147

Add to list

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Thomas Steuber, Cordula Jilg, Pierre Tennstedt, Aurélie De Bruycker (UGent) , D. Tilki, Karel Decaestecker (UGent) , T. Zilli, Barbara Alicja Jereczek-Fossa, Ulrich Wetterauer, Anca-Ligia Grosu, et al.

(2019) EUROPEAN UROLOGY FOCUS. 5(6). p.1007-1013

Add to list

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Aurélie De Bruycker (UGent) , Elise De Bleser, Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Pieter De Visschere (UGent) , Kathia De Man (UGent) , Louke Delrue (UGent) , Bieke Lambert (UGent) and Piet Ost (UGent)

(2019) EUROPEAN UROLOGY. 75(5). p.826-833

Add to list

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Bert Dhondt (UGent) , Elise De Bleser, Tom Claeys, Sarah Buelens (UGent) , Nicolaas Lumen (UGent) , Jo Vandesompele (UGent) , Anneleen Beckers, Valerie Fonteyne (UGent) , Kim Van der Eecken (UGent) , Aurélie De Bruycker (UGent) , et al.

(2019) WORLD JOURNAL OF UROLOGY. 37(12). p.2557-2564

Add to list

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet Ost (UGent) , Dries Reynders (UGent) , Karel Decaestecker (UGent) , Valerie Fonteyne (UGent) , Nicolaas Lumen (UGent) , Aurélie De Bruycker (UGent) , Bieke Lambert (UGent) , Louke Delrue (UGent) , Renée Bultijnck (UGent) , Tom Claeys, et al.

(2018) JOURNAL OF CLINICAL ONCOLOGY. 36(5). p.446-453

Add to list

Journal Article
A1
open access

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Wouter Huysse (UGent) , Frederic Lecouvet, Paolo Castellucci, Piet Ost (UGent) , Valerie Lambrecht (UGent) , Carlos Artigas, Marie-Laurence Denis, Kathia De Man (UGent) , Louke Delrue (UGent) , Lennart Jans (UGent) , et al.

(2017) DIAGNOSTICS. 7(4).

Academic Bibliography

Aurélie De Bruycker

Detection and treatment of oligorecurrent prostate cancer : the next step towards cure

Long-term outcomes and genetic predictors of response to metastasis-directed therapy versus observation in oligometastatic prostate cancer : analysis of STOMP and ORIOLE trials

PEACE V : salvage treatment of oligorecurrent nodal prostate cancer metastases (STORM) : a study protocol for a randomized controlled phase II trial

A trial-based cost-utility analysis of metastasis-directed therapy for oligorecurrent prostate cancer

Re: Gaetan Devos, Gert De Meerleer, Steven Joniau. Have we entered the era of imaging before salvage treatment for recurrent prostate cancer? Eur Urol 2019;76:265-7

Standard of care versus metastases-directed therapy for PET-detected nodal oligorecurrent prostate cancer following multimodality treatment : a multi-institutional case-control study

Nodal oligorecurrent prostate cancer : anatomic pattern of possible treatment failure in relation to elective surgical and radiotherapy treatment templates

Discovery and validation of a serum microRNA signature to characterize oligo- and polymetastatic prostate cancer : not ready for prime time

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Prospective comparison of F-18 choline PET/CT scan versus axial MRI for detecting bone metastasis in biochemically relapsed prostate cancer patients

Contents

Support

Contact